FDA inspection
FUJIFILM Diosynth Biotechnologies UK Limited: FDA inspection ending Mar 17, 2023
FDA inspection 1200417 · Voluntary Action Indicated (VAI) · Billingham
Key facts
| Inspection ID | 1200417 |
|---|---|
| Firm | FUJIFILM Diosynth Biotechnologies UK Limited |
| FEI number | 3007182567 |
| Address | Belasis Avenue |
| City | Billingham |
| Country | United Kingdom |
| Fiscal year | 2023 |
| Inspection end date | Mar 17, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data